Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2018-11-12 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
2017年股票期权激励计划预留部分激励对象名单
Board/Management Information Classification · 95% confidence The document is a list of stock option incentive plan reserved portion recipients, detailing the allocation and names of middle management and core backbone personnel. It is issued by the company's board and dated November 12, 2018. The content focuses on stock option incentive plan details and personnel involved, which is related to management or board information rather than a financial report or announcement of voting results. The document length is short (1214 characters) and does not contain financial statements or earnings data. It is not a report publication announcement or regulatory filing. Therefore, the best fitting category is Board/Management Information (MANG), as it relates to management incentive plans and personnel disclosures.
2018-11-12 Chinese
第三届董事会第二十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 25th meeting of the third board of directors of the company. It details the meeting attendance, the approval of a stock option incentive plan, and voting results. There is no financial data or detailed management discussion, only a formal announcement of board decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2018-11-12 Chinese
独立董事关于公司第三届董事会第二十五次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters related to a specific board meeting of the company, focusing on the approval and conditions of a stock option incentive plan. It references regulatory guidelines and company governance rules but does not contain financial statements or results. It is not a full annual or interim report, nor an earnings release or audit report. It is also not a simple announcement or certification. The content is related to board/management decisions and governance matters, specifically about stock option grants and corporate governance improvements. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and focused on board opinions, not a full report or presentation.
2018-11-12 Chinese
国浩律师（深圳）事务所关于公司2017年股票期权激励计划预留部分授予事项之法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2017 stock option incentive plan reserved portion grant matters of a company. It discusses the approval, authorization, grant date, grant objects, grant quantity, exercise price, and grant conditions related to the stock option plan. The document is not a financial report, earnings release, or regulatory filing about financial results. It is a legal opinion related to a stock option incentive plan, which is a capital/financing activity. The document is detailed and substantive, not a brief announcement or certification. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to stock option grants and incentive plans, which are financing-related activities.
2018-11-12 Chinese
关于子公司获得高新技术企业证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding a subsidiary obtaining a high-tech enterprise certificate, including details about tax benefits and the impact on company performance. It is an official company disclosure but does not contain financial statements, detailed financial data, or comprehensive report content. The length is only 510 characters, indicating it is a brief announcement rather than a full report. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not about management changes, voting results, or legal proceedings. The content is regulatory in nature, informing the market about a material event related to tax status and benefits. Therefore, it best fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2018-11-09 Chinese
关于变更公司名称、经营范围暨完成工商登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding changes to the company name, business scope, and completion of industrial and commercial registration. It includes details about the new company name, legal representative, business scope, and registration information. There is no financial data, no mention of annual or quarterly reports, no voting results, no executive changes, no legal proceedings, and no merger or acquisition activity. The document is relatively short (1235 characters) and serves as an official notification of corporate changes. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-11-09 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.